Ensign Peak Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.82M | Hold |
133,973
| – | – | 0.01% | 570 |
|
|
2025
Q1 | $6.04M | Sell |
133,973
-84,615
| -39% | -$3.81M | 0.01% | 589 |
|
|
2024
Q4 | $9.04M | Sell |
218,588
-1,806
| -0.8% | -$74.7K | 0.02% | 506 |
|
|
2024
Q3 | $8.6M | Sell |
220,394
-2,220
| -1% | -$86.6K | 0.02% | 502 |
|
|
2024
Q2 | $7.61M | Hold |
222,614
| – | – | 0.01% | 520 |
|
|
2024
Q1 | $5.59M | Hold |
222,614
| – | – | 0.01% | 606 |
|
|
2023
Q4 | $6.57M | Hold |
222,614
| – | – | 0.01% | 557 |
|
|
2023
Q3 | $7.03M | Sell |
222,614
-3,086
| -1% | -$97.5K | 0.02% | 485 |
|
|
2023
Q2 | $5.84M | Hold |
225,700
| – | – | 0.01% | 544 |
|
|
2023
Q1 | $5.42M | Hold |
225,700
| – | – | 0.01% | 541 |
|
|
2022
Q4 | $4.4M | Sell |
225,700
-5,250
| -2% | -$102K | 0.01% | 592 |
|
|
2022
Q3 | $4.85M | Buy |
230,950
+73,903
| +47% | +$1.55M | 0.01% | 528 |
|
|
2022
Q2 | $3.06M | Buy |
157,047
+30,654
| +24% | +$597K | 0.01% | 657 |
|
|
2022
Q1 | $2.78M | Hold |
126,393
| – | – | 0.01% | 759 |
|
|
2021
Q4 | $2.02M | Hold |
126,393
| – | – | ﹤0.01% | 950 |
|
|
2021
Q3 | $2.52M | Hold |
126,393
| – | – | 0.01% | 980 |
|
|
2021
Q2 | $2.19M | Hold |
126,393
| – | – | ﹤0.01% | 1085 |
|
|
2021
Q1 | $2.51M | Hold |
126,393
| – | – | 0.01% | 991 |
|
|
2020
Q4 | $2.21M | Buy |
126,393
+100,000
| +379% | +$1.75M | 0.01% | 1004 |
|
|
2020
Q3 | $509K | Buy |
26,393
+24,540
| +1,324% | +$473K | ﹤0.01% | 1527 |
|
|
2020
Q2 | $36K | Hold |
1,853
| – | – | ﹤0.01% | 1666 |
|
|
2020
Q1 | $26K | Sell |
1,853
-2,853
| -61% | -$40K | ﹤0.01% | 1617 |
|
|
2019
Q4 | $116K | Buy |
+4,706
| New | +$116K | ﹤0.01% | 1644 |
|